A Multicenter Phase I/II Study of the BCNU Implant (Gliadel (®) Wafer) for Japanese Patients with Malignant Gliomas

Carmustine (BCNU) implants (Gliadel(®) Wafer, Eisai Inc., New Jersey, USA) for the treatment of malignant gliomas (MGs) were shown to enhance overall survival in comparison to placebo in controlled clinical trials in the United States and Europe. A prospective, multicenter phase I/II study involving...

Descripción completa

Detalles Bibliográficos
Autores principales: AOKI, Tomokazu, NISHIKAWA, Ryo, SUGIYAMA, Kazuhiko, NONOGUCHI, Naosuke, KAWABATA, Noriyuki, MISHIMA, Kazuhiko, ADACHI, Jun-ichi, KURISU, Kaoru, YAMASAKI, Fumiyuki, TOMINAGA, Teiji, KUMABE, Toshihiro, UEKI, Keisuke, HIGUCHI, Fumi, YAMAMOTO, Tetsuya, ISHIKAWA, Eiichi, TAKESHIMA, Hideo, YAMASHITA, Shinji, ARITA, Kazunori, HIRANO, Hirofumi, YAMADA, Shinobu, MATSUTANI, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533485/
https://www.ncbi.nlm.nih.gov/pubmed/24739422
http://dx.doi.org/10.2176/nmc.oa2013-0112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533485/
https://www.ncbi.nlm.nih.gov/pubmed/24739422
http://dx.doi.org/10.2176/nmc.oa2013-0112

Ejemplares similares